These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29649055)

  • 1. The Impact of Once- versus Twice-Daily Enoxaparin Prophylaxis on Risk for Venous Thromboembolism and Clinically Relevant Bleeding.
    Pannucci CJ; Fleming KI; Agarwal J; Rockwell WB; Prazak AM; Momeni A
    Plast Reconstr Surg; 2018 Jul; 142(1):239-249. PubMed ID: 29649055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day Bleeding.
    Pannucci CJ; Fleming KI; Momeni A; Prazak AM; Agarwal J; Rockwell WB
    Plast Reconstr Surg; 2018 Jun; 141(6):1580-1590. PubMed ID: 29608533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.
    Pannucci CJ; Hunt MM; Fleming KI; Prazak AM
    Plast Reconstr Surg; 2017 Oct; 140(4):815-822. PubMed ID: 28953735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate Enoxaparin Dosing Predicts 90-Day Venous Thromboembolism Risk among Plastic Surgery Inpatients: An Examination of Enoxaparin Pharmacodynamics.
    Pannucci CJ; Rockwell WB; Ghanem M; Fleming KI; Momeni A; Agarwal J
    Plast Reconstr Surg; 2017 Apr; 139(4):1009-1020. PubMed ID: 28350685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Dosing of Prophylactic Enoxaparin after Surgical Procedures: Results of the Double-Blind, Randomized, Controlled FIxed or Variable Enoxaparin (FIVE) Trial.
    Pannucci CJ; Fleming KI; Bertolaccini C; Agarwal J; Rockwell WB; Mendenhall SD; Kwok A; Goodwin I; Gociman B; Momeni A
    Plast Reconstr Surg; 2021 Apr; 147(4):947-958. PubMed ID: 33761517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One Size Does Not Fit All: Venous Thromboembolism Prophylaxis in Colorectal Cancer.
    Perrotti G; Sadri L; Fassler M; Sharma D; Kim S; Zebley M; Fassler S
    JSLS; 2020; 24(3):. PubMed ID: 32831542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
    Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
    JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed or Weight-Tiered Enoxaparin After Thoracic Surgery for Venous Thromboembolism Prevention.
    Pannucci CJ; Fleming KI; Bertolaccini C; Moulton L; Stringham J; Barnett S; Lin J; Varghese TK
    Ann Thorac Surg; 2020 Jun; 109(6):1713-1721. PubMed ID: 32045583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
    Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
    J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
    Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
    Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
    J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical Procedure.
    Pannucci CJ; Fleming KI; Holoyda K; Moulton L; Prazak AM; Varghese TK
    Ann Thorac Surg; 2018 Aug; 106(2):404-411. PubMed ID: 29626461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
    Walker CK; Sandmann EA; Horyna TJ; Gales MA
    Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-Daily Versus Twice-Daily Enoxaparin for the Treatment of Acute Venous Thromboembolism in Cancer Patients.
    Fuller K; Malecki S; Anselmo L; Borrego ME; Jakeman B; Burnett A
    Ann Pharmacother; 2018 Mar; 52(3):257-262. PubMed ID: 29025276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism.
    Trujillo-Santos J; Bergmann JF; Bortoluzzi C; López-Reyes R; Giorgi-Pierfranceschi M; López-Sáez JB; Ferrazzi P; Bascuñana J; Suriñach JM; Monreal M
    J Thromb Haemost; 2017 Mar; 15(3):429-438. PubMed ID: 28120516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?
    Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS
    Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.
    Fuji T; Wang CJ; Fujita S; Kawai Y; Nakamura M; Kimura T; Ibusuki K; Ushida H; Abe K; Tachibana S
    Thromb Res; 2014 Dec; 134(6):1198-204. PubMed ID: 25294589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis: A Pooled Analysis of Eight Clinical Trials.
    Pannucci CJ; Fleming KI; Varghese TK; Stringham J; Huang LC; Pickron TB; Prazak AM; Bertolaccini C; Momeni A
    Ann Surg; 2022 Dec; 276(6):e682-e690. PubMed ID: 33086312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial.
    Shorr AF; Eriksson BI; Jaffer AK; Smith J
    J Thromb Haemost; 2012 Aug; 10(8):1515-20. PubMed ID: 22672318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.